Navigation Links
AMERIGROUP Foundation Supports Groundbreaking on Grommet Island Park for People With Disabilities
Date:10/4/2009

VIRGINIA BEACH, Va., Oct. 4, 2009 /PRNewswire/ -- The AMERIGROUP Foundation teamed up with the ALS Association today in support of a 4K walk, groundbreaking and beach party to benefit the Grommet Island park project - a first of its kind, 100 percent handicap-accessible oceanfront destination - in Virginia Beach.

During the walk, volunteers on behalf of the Foundation joined with other local leaders and officially 'broke ground' on the 15,000-square-foot project born out of inaccessibility to the beach for those with disabilities and noted by Virginia Beach native Josh Thompson (JT). Thompson suffers from amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease), and his family decided to do something about the lack of beach access for those like him. With the help of friends and community partners such as AMERIGROUP, JT's Grommet Island Beach Park was born. Located just off the Boardwalk (between 1st and 2nd Streets), the project will feature a park and cutting edge play structure with 'all-ability-friendly' equipment.

"Imagine a park where children and adults with disabilities have the 'ability' to experience the sun, sand and surf just as those without disabilities do. That is the vision behind JT's Grommet Island Park and Playground for EveryBODY," said John E. Littel, Chairman of the AMERIGROUP Foundation.

The AMERIGROUP Foundation donated $100,000 to assist in the construction of the Oceanside Park and for the ALS Association. Proceeds raised from today's walk will also go toward the project, which is scheduled for completion in 2010.

"From the beginning, AMERIGROUP has really gotten behind this project, and we are thrilled by their support," said Bruce Thompson, Josh's father, who is spearheading the efforts for the park. "This is an innovative collaboration, and one that helps so many communities, from those with disabilities to people in Hampton Roads and beyond. We certainly didn't have to convince AM
'/>"/>

SOURCE AMERIGROUP Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. AMERIGROUP Corporation to Present at the CIBC World Markets 18th Annual Healthcare Conference on November 5
2. AMERIGROUP Reaches Agreement in Principle to Settle Illinois Qui Tam Litigation
3. AMERIGROUP Corporation to Discuss Third Quarter Earnings on October 23
4. AMERIGROUP Corporation Named One of Best Places to Work in Healthcare
5. AMERIGROUP Praises Expansion of State Childrens Health Insurance Program (SCHIP)
6. GeneGo and the Cystic Fibrosis Foundation Collaborate to Advance Understanding of Cystic Fibrosis
7. More Than 230 Cyclists to Ride in Amgen California Coast Classic Bike Tour to Raise $1.3 Million for Arthritis Foundation
8. International Atomic Energy Agency and National Foundation for Cancer Research Launch Major Initiative to Improve Cancer Prevention and Treatments in Developing Countries
9. Melanoma Research Foundation and Seattle Cancer Care Alliance Host Educational Symposium and Reception for Melanoma Patients, Family Members and Healthcare Providers
10. Foundation for Biomedical Research Board Chairman Awarded Congressional Gold Medal
11. The Parkinsons Disease Foundation Commemorates its 50th Anniversary with Special Scientific Symposium on Parkinsons Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ... July 30, 2015 , ... Leading regenerative veterinary medicine ... its canine osteoarthritis stem cell product, currently under development for FDA approval. The ... be marketed in the US by Aratana. This product, termed AT-016, is an ...
(Date:7/30/2015)...   Senomyx , Inc. (NASDAQ: SNMX ), ... discover, develop, and commercialize novel flavor ingredients for the ... results for the second quarter 2015. ... on track to achieve our commercial and financial goals," ... the Company. "Since our last quarterly earnings report, our ...
(Date:7/30/2015)... July 30, 2015 Ascendis Pharma A/S ... applies its innovative TransCon technology to address significant ... from a six-month Phase 2 study to evaluate ... Hormone in 53 treatment-naïve, pre-pubertal children with growth ... extremely pleased with the top-line results from our ...
(Date:7/30/2015)... , July 30, 2015  Discovery Laboratories, ... it has received the second $1.0M tranche under ... Research (SBIR) grant valued at up to $3.0 ... aerosolized KL4 surfactant as a potential medical countermeasure ...  Discovery Labs was awarded an initial $1.0 million ...
Breaking Biology Technology:VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 2SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 5SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 6SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 7SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 8SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 9Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 2Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 3
... , , , SAN DIEGO, ... Company will present at the following investor conferences: , , , ... p.m. Eastern Time (ET) on September 9. , Thomas Weisel ... The 2009 Morgan Stanley Global Healthcare Unplugged Conference in New ...
... , , SUNNYVALE, Calif., Sept. ... biopharmaceutical company focused on developing and commercializing innovative small molecule ... today announced that Dr. Glenn Rice, President and COO, will ... , -- Thomas Weisel Partners 2009 Healthcare Conference ...
... , , EMERYVILLE, Calif., ... announced today that new research data will be delivered as ... Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco, CA on ... multi-institutional collaborative in vitro study of Adamas, triple ...
Cached Biology Technology:Gen-Probe to Webcast Four Upcoming Investor Presentations 2Pharmacyclics to Present and Webcast at Upcoming Life Sciences Investor Conferences 2Adamas Pharmaceuticals to Present Data on Triple Combination Antiviral Drug Therapy for Drug-Resistant Influenza at 2009 ICAAC Annual Meeting 2
(Date:7/27/2015)... 27, 2015   Zynx Health ™, the ... improvement solutions, today announced that its ZynxCarebook ... on Android smartphones and tablets. With this expansion, ... can use ZynxCarebook to securely exchange messages and ... care transitions to other care settings, and improve ...
(Date:7/21/2015)... July 21, 2015  NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce ... announces that it has filed provisional patent 62/192218 ... This invention highlights next generation ... an account, but also the user using unique ...
(Date:7/13/2015)... , Jul. 13, 2015 NXT-ID, Inc. ... a biometric authentication company focused on the growing ... filed provisional patent 62/188684 for BEHAVIORAL-DIRECTED ... another new convenient and secure method to make ... innovative payment methods, introduced with its groundbreaking voice-direct ...
Breaking Biology News(10 mins):Zynx Health Adds Android Device Support to ZynxCarebook Solution 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4
... Developmental Biology and the University of North Carolina at ... by a small number of genes, can be a ... thaliana, sometimes called thale cress, the researchers identified a ... female, produced plants that survived only long enough to ...
... two species oscillate together (for example, predators and prey), its ... famous example is the Canadian lynx and snowshoe hare, documented ... is the opposite also true" If the preys population doesnt ... not tightly linked in the food web" Among ecologists, this ...
... domesticated pigs in Europe, which many archaeologists believed to ... from the Middle East by Stone Age farmers, new ... led by archaeologists at Durham University, which is published ... Academies of Sciences USA, analysed mitochondrial DNA from ancient ...
Cached Biology News:Auto immune response creates barrier to fertility; could be a step in speciation 2Hidden interactions between predators and prey: evolution causes cryptic dynamics in ecology 2Pig study sheds new light on the colonisation of Europe by early farmers 2
Hygromycin resistance gene (hph), provided in a pORF plasmid. pORF is an expression plasmid selectable with Ampicillin....
... provides a simple and efficient means for ... lture using annexin V magnetic beads (MagBeads). ... protein with high affinity for phosphatidylseri ... simple and efficient means for isolation of ...
... This CLS number is a ... easily match Cornings product number. ... please order under the old ... customer service for assistance. ID ...
... combines top performance with exquisite design. The ... and unparalleled temperature uniformity. The instrument has ... a spreadsheet or alternatively in a graphical ... on the push of a button and ...
Biology Products: